Affiliations 

  • 1 Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China. Electronic address: scwtang@hku.hk
  • 2 Institute of Nephrology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
  • 3 Renal Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
  • 4 Department of Nephrology and Hypertension, Kawasaki Medical School, Okayama, Japan
  • 5 Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
  • 6 Department of Renal Medicine, Tan Tock Seng Hospital, Singapore
  • 7 Department of Nephrology & Clinical Research Centre, Hospital Serdang, Kuala Lumpur, Malaysia
  • 8 Department of Internal Medicine, Daniel O. Mercado Medical Center, Batangas, Philippines
  • 9 Department of Medical Services, Rajavithi Hospital, Ministry of Public Health, Bangkok, Thailand
  • 10 RIPAS Hospital, Bandar Seri Begawan, Brunei Darussalam
  • 11 Mercy Medical Center Cambodia, Phnom Penh, Cambodia
  • 12 Division of Nephrology and Hypertension, Department of Internal Medicine, Medical Faculty-Universitas Indonesia, Jakarta, Indonesia
  • 13 Department of Internal Medicine, BP Koirala Institute of Health Sciences, Dharan, Nepal
  • 14 Department of Nephrology, Holy Family Red Crescent Medical College and Hospital, Dhaka, Bangladesh
  • 15 Department of Internal Medicine, Mongolian National University of Medical Sciences School of Medicine, Ulaanbaatar, Mongolia
  • 16 Department of Internal Medicine and Nephrology, The Specialty Hospital, Amman, Jordan
  • 17 The George Institute for Global Health, New Delhi, India; The George Institute for Global Health, University of Oxford, Oxford, United Kingdom; Department of Medicine, University of New South Wales, Sydney, Australia; Manipal Academy of Higher Education, Manipal, India
Am J Kidney Dis, 2020 05;75(5):772-781.
PMID: 31699518 DOI: 10.1053/j.ajkd.2019.08.005

Abstract

Asia is the largest and most populated continent in the world, with a high burden of kidney failure. In this Policy Forum article, we explore dialysis care and dialysis funding in 17 countries in Asia, describing conditions in both developed and developing nations across the region. In 13 of the 17 countries surveyed, diabetes is the most common cause of kidney failure. Due to great variation in gross domestic product per capita across Asian countries, disparities in the provision of kidney replacement therapy (KRT) exist both within and between countries. A number of Asian nations have satisfactory access to KRT and have comprehensive KRT registries to help inform practices, but some do not, particularly among low- and low-to-middle-income countries. Given these differences, we describe the economic status, burden of kidney failure, and cost of KRT across the different modalities to both governments and patients and how changes in health policy over time affect outcomes. Emerging trends suggest that more affluent nations and those with universal health care or access to insurance have much higher prevalent dialysis and transplantation rates, while in less affluent nations, dialysis access may be limited and when available, provided less frequently than optimal. These trends are also reflected by an association between nephrologist prevalence and individual nations' incomes and a disparity in the number of nephrologists per million population and per thousand KRT patients.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.